Sichuan Biokin Pharmaceutical Co., Ltd. (02615)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Chen Yingge | 01-Jun-24 | BrdSec | |||
| Dai Zewei | 01-Sep-25 | INED, ChAC, MbAC, MbNC, MbCC | |||
| David Guowei Wang | 01-Aug-17 | NED | |||
| He Yong | 01-Sep-23 | VP | |||
| Ho Wing Nga | 17-Nov-25 | CoSec, AuRep | |||
| Li Mingyuan | 01-Nov-20 | INED, MbAC, ChNC, MbNC, MbStrC | |||
| Wan Weili | 01-Sep-25 | ED | |||
| Wang Xiaoxiao | 01-Sep-23 | VP | |||
| Xiao Geng | 01-Jul-24 | INED, MbAC, ChCC, MbCC, MbStrC | |||
| Zhang Suya | 01-Aug-06 | ED, Dep GM, CFO, AuRep, MbNC, MbCC | |||
| Zhu Hai | 01-Feb-24 | ED | |||
| Zhu Yi | 01-Nov-10 | ED, Ch, GM, CSciO, ChStrC, MbStrC | |||
| Zhuo Shi | 01-Mar-21 | ED |